Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments

 Anaesthetics

 Anthelmintic

 Anti Hypertensives

 Anti- Ulcler Agents

 Anti-Asthamatic

 Anti-Diabetic

 Anti-Fungal

 Anti-Histamines

 Anti-Microbials

 Anti-Tussives

 Drugs In Osteoporosis

 Haematinic And Nutritional Supplement

 NSAIDs

 Skeletal Muscle Relaxants

 Oncology API
 Specialty APIs
 Chiral intermediates
Anti-Tussives
Salmaplon 2mg Each uncoated tablet contains: Salbutamol sulphate IP.equivalent to Salbutamol 2 mg
Salmaplon 4mg Each uncoated tablet contains: Salbutamol sulphate IP.equivalent to Salbutamol 4 mg
Exiplon Each 5ml contains : Codeine Phosphate - 10mg + Chlorpheniramine Maleate - 4mg
Exiplon dm Each 5 ml contains:Dextromethorphan hydrobromide I.P 10mg Chlorpheniramine Maleate IP 4mg Flavoured syrupy base q.s.
Exiplon br Each 5 ml. contains: Salbutamol sulphate IP equivalent to Salbutamol 1mg Bromhexine hydrochloride IP 2mg+Guaiphenesin IP 50mg+Menthol IP 0.5mg
Exol syrup Each 5ml contains:Sulbutamol sulphate I.P.equivalent to Salbutamol 1mg Ambroxol Hydrochloride 30mg + Guaiphensin IP 50mg +Menthol IP 0.5mg In flavoured syrupy base
Prenoxid 200mg tablet Each filmcoated tablet contains:Prenoxdiazine hydrochloride 200 mg
Prenoxid 100mg tablet Each filmcoated tablet contains:Prenoxdiazine hydrochloride 100 mg
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.